FDA Approved: GENGRAF — Supplemental Application (AbbVie Inc.)

View source ↗

Summary

FDA approved AbbVie's supplemental application for GENGRAF (cyclosporine), updating the product's approval status under the ANDA process.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplant Rejection
• Kidney Transplant Rejection
• Liver Transplant Rejection

Drugs mentioned

• GENGRAF (cyclosporine)

Snippet

SUPPL AP for GENGRAF (CYCLOSPORINE)